← SynDRA
ADAROTENE
SynDRA canonical compound SYN0004317 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | RARA | RARB | RARG |
| Mechanism of action | retinoid receptor agonist |
All known targets
Mechanisms of action (all sources)
- retinoid receptor agonist
Cross-references
Synonyms
- Adarotene ester derivative back-up compounds
- Adarotene ester derivative back-up compounds (cancer)
- Adarotene ester derivative back-up compounds (cancer), Sigma-Tau
- Adarotene [INN]
- ST1926
- W6SU73VG8H
- CHEMBL442016
- (2E)-3-(4'-Hydroxy-3'-tricyclo[3.3.1.13,7]dec-1-yl[1,1'-biphenyl]-4-yl)-2-propenoic acid
- (E)-3-(3'-((3r,5r,7r)-adamantan-1-yl)-4'-hydroxy-[1,1'-biphenyl]-4-yl)acrylic acid
- UNII-W6SU73VG8H
- ST-1926
- ADAROTENE [WHO-DD]
- SCHEMBL403527
- SCHEMBL403528
- 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid
- DTXSID9040390
- ZINC3990465
- BDBM50124518
- CS-0678
- (2E)-3-(3'-(A(4Sdamantan-1-yl)-4'-hydroxy-1,1'-biphenyl-4-yl)prop-2-enoic acid
- NCGC00485908-01
- AS-74260
- HY-14808
- C75317
- A913875
- E-4-(3-(1-adamantyl)-4-hydroxyphenyl)cinnamic acid
- Q15633950
- (E)-4-[3-(1-adamantyl)-4-hydroxyphenyl]cinnamic acid
- (E)-3-(3''-Adamantan-1-yl-4''-hydroxy-biphenyl-4-yl)-acrylic acid
- (E)-3-[4-[3-(1-adamantyl)-4-hydroxyphenyl]phenyl]prop-2-enoic acid
- (2E)-3-(3'-(ADAMANTAN-1-YL)-4'-HYDROXY-1,1'-BIPHENYL-4-YL)PROP-2-ENOIC ACID
- (2E)-3-[3'-(adamantan-1-yl)-4'-hydroxy-[1,1'-biphenyl]-4-yl]prop-2-enoic acid
- (2E)-3-[4'-hydroxy-3'-(tricyclo[3.3.1.13,7]dec-1-yl)biphenyl-4-yl]prop-2-enoic acid
- 2-Propenoic acid, 3-(4'-hydroxy-3'-tricyclo(3.3.1.13,7)dec-1-yl(1,1'-biphenyl)-4-yl)-, (2E)-
- adaroteno
- adarotenum
- RefChem:552953
- DTXCID7020390
Look up ADAROTENE in the interactive SynDRA portal →